Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1038, 2005-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Safety updates from New Zealand's Medsafe
Reactions Weekly, Vol. 1, Iss. 1383, 2012-01 ,pp. :
Access to resources
Recommend
Concern that Medsafe may stop funding the New Zealand IMMP
Reactions Weekly, Vol. 1, Iss. 1009, 2004-01 ,pp. :
Concern that Medsafe may stop funding the New Zealand IMMP
Inpharma, Vol. 1, Iss. 1445, 2004-01 ,pp. :
FDA is reviewing safety of omalizumab
Reactions Weekly, Vol. 1, Iss. 1262, 2009-01 ,pp. :
Activities to promote quality use of medicines in New Zealand
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 472, 2005-01 ,pp. :